The bio-based 1,4-butanediol market was valued at 27.11 kilotons in 2021, and it is expected to witness a CAGR of approximately 25.69% during the forecast.
PETALING JAYA: The healthcare sector can look forward to a resilient earnings in 2023, particularly among players in the private hospitals, pharmaceuticals and over-the-counter (OTC) drugs as well as immunotherapy.